Jsl Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.47 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth 421.50%
- Ebitda 479081.68%
- Net Worth 3996.76%
- Total Assets 21.36%
About Jsl Health Sciences
Jsl Health Sciences Private Limited (JHSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and six months 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.47 M.
The company currently has active open charges totaling ₹2.00 Cr.
Venkata Chittala and Appala Lanka serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110TG2020PTC142645
- Company No.
142645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2020
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Jsl Health Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Chittala  | Director | 08-Aug-2020 | Current |
| Appala Lanka | Director | 08-Aug-2020 | Current |
Financial Performance of Jsl Health Sciences.
Jsl Health Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 421.5% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 3996.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jsl Health Sciences?
In 2023, Jsl Health Sciences had a public holding of 53.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vertical Riser Projects LlpVenkata Chittala is a mutual person
- Cenote Healthcare Private Limited
Venkata Chittala is a mutual person
- Atmus Pharma Private Limited
Venkata Chittala is a mutual person
Charges (Loans)
₹2.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2023 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Jsl Health Sciences?
Unlock and access historical data on people associated with Jsl Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jsl Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jsl Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.